Gliknik Inc

SEC filing

Biotechnology · Baltimore, MD

Form D on EDGAR

Amount raised$15Msold at filing

Total offering$15M

Investors in the raise11count reported to the SEC

FiledSep 17, 2026first sale Aug 15, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Paul S. FreidmanDirector

Charles S. PolskyDirector

Raymond S. SchinaziDirector

Kyle S. RusconiDirector

David S. BroserDirector

Elizabeth S. BlockExecutive Officer

Richard S. LevyDirector

David S. BlockExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.

Form	Filed	Amount sold	Offering
D/A	Sep 17, 2026	$15M	$15M	EDGAR
D	Aug 21, 2025	$11M	$15M	EDGAR
D/A	Jan 24, 2025	$5.3M	$6M	EDGAR
D	Nov 21, 2024	$2M	$5M	EDGAR